A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

The solution automatically labels subdural collections and reports measurements such as thickness, midline shift, and volume.

This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s ...

Ambient listening software is part of a buzzy new technology being marketed as AI “scribes,” or assistants, to help doctors ...

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

Simulations Plus faces weak biopharma demand, slowing growth, margin pressure, and high valuation amid M&A reliance. See why ...

There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms and progression, ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...